pH Pharma Overview

  • Founded
  • 2015

Founded
  • Status
  • Private

  • Employees
  • 55

Employees
  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $6.82M

  • Investors
  • 5

pH Pharma General Information

Description

Developer of pharmaceutical drugs intended to provide treatment of various chronic diseases. The company's drugs offer Rho Kinase inhibitor for the treatment of normal-tension glaucoma without conjunctival congestion and neutrophil elastase inhibitor that neutralizes the physiologically active form of the target enzyme in liver diseases, enabling medical practitioners to treat patients suffering from glaucoma and Nonalcoholic fatty liver disease easily.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • B-804, U-Space 2, 670 Daewangpangyo-ro
  • Bundang-gu
  • Seongnam-si, Gyeonggi-do 13494
  • South Korea
+82 000-000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

pH Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 01-Jan-2020 $6.82M 00.000 00000 Completed Clinical Trials - Phase 2
3. Early Stage VC (Series B) 01-Jan-2018 Completed Startup
2. Early Stage VC (Series A) 01-Apr-2016 Completed Startup
1. Accelerator/Incubator 01-Jan-2015 Completed Startup
To view pH Pharma’s complete valuation and funding history, request access »

pH Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of pharmaceutical drugs intended to provide treatment of various chronic diseases. The company's drugs offer R
Drug Discovery
Seongnam-si, South Korea
55 As of 2022
00.000
0000 0000-00-00
0000000000 0 00.000

000 00

ehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cu
0000 000000000
Barcelona, Spain
00 As of 0000
0000
00000000000 0000

000000

elit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, su
0000 000000000
Boston, MA
00 As of 0000
0000
00.00 0000-00-00
00000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

pH Pharma Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ona Therapeutics Venture Capital-Backed Barcelona, Spain 00 0000 00000000000 0000
00000000 Venture Capital-Backed Boston, MA 00 0000 00000000000 0000
0000000 000000 Venture Capital-Backed Barcelona, Spain 00 0000 000000000000 0000
00 000000000000 Formerly VC-backed Durham, NC 000 00000 000000 - 000 00000
0000000 Venture Capital-Backed Solna, Sweden 0 00.000 0000000000 0 00.000
You’re viewing 5 of 14 competitors. Get the full list »

pH Pharma Patents

pH Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020340281-A1 Use of a neutrophil elastase inhibitor in lung disease Pending 23-Aug-2019 000000000
CA-3151997-A1 Use of a neutrophil elastase inhibitor in lung disease Pending 23-Aug-2019 000000000
EP-4017497-A1 Use of a neutrophil elastase inhibitor in lung disease Pending 23-Aug-2019 000000000
US-20220296597-A1 Use of a neutrophil elastase inhibitor in lung disease Pending 23-Aug-2019 0000000000
AU-2019257632-A1 Use of neutrophil elastase inhibitors in liver disease Pending 24-Apr-2018 A61K31/513
To view pH Pharma’s complete patent history, request access »

pH Pharma Executive Team (4)

Name Title Board Seat Contact Info
Hoyoung Huh Ph.D Founder, Co-Chief Executive Officer & Chairman
Jaesoon Kim Co-Chief Executive Officer & Board Member
Sang Hoon Paik Ph.D Managing Director & Head of ASIA Research Center
You’re viewing 3 of 4 executive team members. Get the full list »

pH Pharma Board Members (7)

Name Representing Role Since
Hoyoung Huh Ph.D pH Pharma Founder, Co-Chief Executive Officer & Chairman 000 0000
Jaesoon Kim pH Pharma Co-Chief Executive Officer & Board Member 000 0000
Jungmin Jo Self Board Member 000 0000
Nevan Elam JD Self Board Member 000 0000
Young-jin Kim Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

pH Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

pH Pharma Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
YK Venture Partners Venture Capital Minority 000 0000 000000 0
Magna Investment Venture Capital Minority 000 0000 000000 0
Red Badge Management Venture Capital Minority 000 0000 000000 0
SBI Investment Korea Company Venture Capital Minority 000 0000 000000 0
MBC BioLabs Accelerator/Incubator Minority 000 0000 000000 0
To view pH Pharma’s complete investors history, request access »

pH Pharma Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 15-Sep-2016 00000 0000 00000 Personal Products
Rezolute 29-Jun-2016 PIPE 0000 Drug Discovery 0000000 0
To view pH Pharma’s complete investments history, request access »

pH Pharma Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000000 15-Sep-2016 00000 00000 00 00000 Completed
  • 00 000000
To view pH Pharma’s complete exits history, request access »